Jim Simons Glycomimetics Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Glycomimetics Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 781,100 shares of GLYC stock, worth $179,653. This represents 0.0% of its overall portfolio holdings.

Number of Shares

781,100

Previous 826,851 5.53%

Holding current value

$179,653

Previous $231,000 42.86%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.16 - $0.32 $7,320 - $14,640	-45,751 Reduced 5.53%	781,100 $132,000
Q2 2024 Aug 09, 2024	BUY	$0.24 - $3.04 $164,436 - $2.08 Million	685,151 Added 483.52%	826,851 $231,000
Q1 2024 May 13, 2024	BUY	$2.55 - $3.49 $44,002 - $60,223	17,256 Added 13.87%	141,700 $425,000
Q4 2023 Feb 13, 2024	SELL	$1.13 - $2.54 $86,629 - $194,724	-76,663 Reduced 38.12%	124,444 $294,000
Q3 2023 Nov 14, 2023	BUY	$1.29 - $1.73 $109,659 - $147,062	85,007 Added 73.22%	201,107 $302,000
Q2 2023 Aug 11, 2023	SELL	$1.21 - $2.08 $32,670 - $56,160	-27,000 Reduced 18.87%	116,100 $202,000
Q1 2023 May 12, 2023	SELL	$1.25 - $4.05 $142,375 - $461,295	-113,900 Reduced 44.32%	143,100 $180,000
Q4 2022 Feb 13, 2023	SELL	$0.57 - $3.03 $153,501 - $815,979	-269,300 Reduced 51.17%	257,000 $779,000
Q3 2022 Nov 14, 2022	SELL	$0.55 - $0.9 $22,055 - $36,090	-40,100 Reduced 7.08%	526,300 $290,000
Q2 2022 Aug 12, 2022	BUY	$0.54 - $1.15 $51,732 - $110,169	95,800 Added 20.36%	566,400 $339,000
Q1 2022 May 13, 2022	SELL	$1.0 - $1.58 $130,700 - $206,506	-130,700 Reduced 21.74%	470,600 $536,000
Q4 2021 Feb 11, 2022	BUY	$1.44 - $2.14 $7,488 - $11,128	5,200 Added 0.87%	601,300 $866,000
Q3 2021 Nov 12, 2021	SELL	$1.8 - $2.39 $290,867 - $386,207	-161,593 Reduced 21.33%	596,100 $1.31 Million
Q2 2021 Aug 13, 2021	BUY	$2.16 - $3.18 $283,376 - $417,193	131,193 Added 20.94%	757,693 $1.76 Million
Q1 2021 May 13, 2021	SELL	$2.89 - $4.22 $259,522 - $378,956	-89,800 Reduced 12.54%	626,500 $1.89 Million
Q4 2020 Feb 10, 2021	BUY	$2.69 - $4.24 $1.24 Million - $1.96 Million	461,600 Added 181.23%	716,300 $2.69 Million
Q3 2020 Nov 13, 2020	SELL	$3.07 - $5.0 $1 Million - $1.63 Million	-326,900 Reduced 56.21%	254,700 $782,000
Q2 2020 Aug 13, 2020	BUY	$2.06 - $3.76 $531,533 - $970,177	258,026 Added 79.74%	581,600 $2.19 Million
Q1 2020 May 14, 2020	BUY	$1.83 - $5.41 $592,140 - $1.75 Million	323,574 New	323,574 $738,000
Q1 2019 May 14, 2019	SELL	$9.96 - $13.44 $869,249 - $1.17 Million	-87,274 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$8.47 - $14.71 $739,210 - $1.28 Million	87,274 New	87,274 $826,000

Others Institutions Holding GLYC

# of Institutions

Shares Held

17.8M

Call Options Held

Put Options Held

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $12.1M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account